BioPharma Credit PLC
BOPCFOTCFinancial Services● Active
$0.91
+$0.91(+82064.72%)
Market Cap$1.0B
P/E Ratio—
52W High$1.02
52W Low$0.8364
BioPharma Credit PLC (BOPCF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BOPCF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.14B | $0.12B | $0.14B | $0.18B | $0.09B |
| Cost of Revenue | $0.03B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.11B | $0.12B | $0.14B | $0.18B | $0.09B |
| Gross Margin %(computed) | 81.65% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.03B | $0.00B | $0.00B |
| Total Operating Expenses | ($0.02B) | $0.00B | $0.03B | $0.00B | $0.00B |
| Operating Income | $0.13B | $0.12B | $0.11B | $0.18B | $0.08B |
| Operating Margin %(computed) | 92.60% | 98.17% | 79.90% | 98.95% | 96.58% |
| Interest Income | $0.14B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.13B | $0.12B | $0.11B | $0.18B | $0.08B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.13B | $0.12B | $0.11B | $0.18B | $0.08B |
| Net Margin %(computed) | 92.62% | 98.17% | 79.90% | 98.95% | 96.58% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.11 | $0.10 | $0.08 | $0.13 | $0.06 |
| Wtd Avg Shares | 1.14B | 1.22B | 1.31B | 1.36B | 1.37B |
| EBITDA | $0.13B | $0.12B | $0.00B | $0.00B | $0.00B |
| EBITDA Margin %(computed) | 92.62% | 98.17% | 0.00% | 0.00% | 0.00% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more BioPharma Credit PLC data
About BioPharma Credit PLC (BOPCF) Income Statement
BioPharma Credit PLC (BOPCF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BOPCF reported revenue of $0.14B, gross profit of $0.11B (gross margin 81.65%), and net income of $0.13B — a net profit margin of 92.62%.
Frequently asked questions
BOPCF · 4 questionsBioPharma Credit PLC (BOPCF) reported revenue of $0.14B for 2025, up 12.7% year-over-year.
BOPCF revenueBOPCF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08